Hepanib 200 mg


Hepanib 200 mg

Introduction to Hepanib 200 mg

Hepanib 200 , meticulously formulated by Everest Pharmaceuticals Ltd and supplied by Orio Pharma, represents a significant advancement in the treatment of liver cancer. The active ingredient in Hepanib, a potent anticancer agent, offers a targeted approach, providing hope and improved outcomes for individuals battling liver cancer.

Description: Hepanib 200 mg

Hepanib 200 contains a powerful therapeutic agent specifically designed to combat liver cancer. This medication is formulated to interfere with the growth and spread of cancer cells, offering a targeted and effective treatment option for liver cancer patients.

Mechanism of Action

Hepanib 200 works by targeting specific pathways involved in the growth and proliferation of cancer cells within the liver. By inhibiting these pathways, Hepanib effectively suppresses tumor growth and aids in preventing the spread of cancer within the body.

Clinical Use

Hepanib 200 is primarily indicated for:

  • Liver Cancer Treatment: Prescribed for the treatment of advanced or metastatic liver cancer, providing a potent option to manage the disease.

Dosage and Administration

Healthcare professionals determine the appropriate dosage of Hepanib 200 based on the specific condition and the individual patient’s response. Administered according to a precise schedule, adherence to the prescribed regimen is crucial for achieving optimal results.

Benefits of Hepanib 200 mg

  • Targeted Therapy: Hepanib’s precise mechanism of action targets cancer cells in the liver, minimizing damage to healthy cells.
  • Tumor Growth Suppression: Effectively inhibits tumor growth, leading to disease stabilization and potentially improved survival rates.
  • Advanced Treatment: Offers a modern, advanced treatment option for individuals with liver cancer, improving their quality of life and treatment outcomes.

Manufacturer: Everest Pharmaceuticals Ltd

Everest Pharmaceuticals Ltd, the esteemed manufacturer of Hepanib 200 , is dedicated to producing high-quality anticancer medications. Their commitment to innovation and stringent quality control ensures that Hepanib meets the highest standards of efficacy and safety.

Supplier: Orio Pharma

Orio Pharma, the trusted supplier of Hepanib 200 , ensures that this crucial medication is accessible to healthcare providers and patients worldwide. Their dedication to excellence in distribution guarantees timely and reliable access to Hepanib.

Storage Conditions

Store Hepanib 200 tablets at room temperature, between 20°C to 25°C (68°F to 77°F). Protect from moisture and light. Keep the tablets in their original container and keep out of reach of children.


In conclusion, Hepanib 200 is a groundbreaking medication for the treatment of advanced liver cancer. Manufactured by Everest Pharmaceuticals Ltd and supplied by Orio Pharma, this treatment offers a targeted and effective approach to combatting liver cancer.

The innovative action of Hepanib underscores its role as a potent therapeutic option. The collaboration between Everest Pharmaceuticals Ltd and Orio Pharma ensures the highest standards of manufacturing and distribution, making Hepanib 200 a reliable and accessible option for patients seeking improved outcomes in their fight against liver cancer.